Recent Finacing
Recent Raise
Harbour BioMed develops fully human antibodies and bispecifics using proprietary Harbour Mice transgenic platforms and HBICE tech, licensing platforms and advancing clinical programs from US, European and Chinese sites.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Harbour Biomed.
